Please login to the form below

Not currently logged in
Email:
Password:

KYNE bolsters digital offering

Medit will take the helm of KYNE’s digital strategy

KYNESpeciality health communications agency KYNE is boosting its digital offering with the help of AI-focused group Medit.

Under a new agreement, Julie O’Donnell, co-founder of Medit, will lead KYNE’s digital strategy and expand its digital resources as the company’s new global head of digital.

She said: “Having worked directly with the team, I can say that KYNE’s passion to create positive change in healthcare through innovative partnerships really fits with our mission at Medit.”

Medit aims to make medical education more ‘efficient’, supporting peer-to-peer learning and collaboration.

O’Donnell added: “KYNE’s unique perspective and network will really contribute to the success of Medit’s global launch, and no doubt, together we’ll have an impact in improving content discovery and sharing in healthcare.”

Prior to launching Medit, O’Donnell led digital and social marketing integration at Lundbeck.

David Kyne, fonder and CEO of KYNE, said: “As our industry continues its rapid rate of change, it is imperative that we look to technology partners like Medit and great talent like Julie to stay at the forefront of innovation in healthcare communications.

“Our investment in Medit is reflective of our continued focus on digital and the rapid growth KYNE has experienced in recent years.

“Combining Medit’s innovative technology with KYNE’s strategic communications efforts will further strengthen solutions we offer to our clients.”

Article by
Gemma Jones

8th May 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics